U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681076) titled 'Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers' on June 26.

Brief Summary: This study looks at how to reduce nausea and vomiting in people taking KarXT which is used to treat mental health conditions like schizophrenia. KarXT can cause stomach-related side effects, especially in the first couple of weeks. In this study, healthy volunteers will take KarXT along with anti-nausea medication, either regularly (to prevent symptoms) or as needed.

The goal is to see how well these strategies help reduce nausea and vomiting and how safe the combination is. The results will help doct...